Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran N Hari

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Multiple myeloma: future directions in autologous transplantation and novel agentsParameswaran N Hari, Philip L McCarthy
The New England Journal of Medicine|October 1, 2015
Ibrutinib in Refractory Classic Hodgkin's LymphomaMehdi Hamadani, Sriram Balasubramanian, Parameswaran N Hari
Expert Review of Hematology|May 3, 2014
Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of ageLaura C Michaelis, Mehdi Hamadani, Parameswaran N Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myelomaLuciano J Costa, Jia-Xing Huang, Parameswaran N Hari
Leukemia & Lymphoma|April 23, 2016
Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validityLuciano J Costa, Parameswaran N Hari, Shaji K Kumar
World Journal of Transplantation|October 1, 2015
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomasNarendranath Epperla, Timothy S Fenske, Parameswaran N Hari, et al.
Bone Marrow Transplantation|August 10, 2020
Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challengesBinod Dhakal, Parameswaran N Hari, Saad Z Usmani, et al.
Statistics in Medicine|January 9, 2017
Instrumental variable with competing risk modelCheng Zheng, Ran Dai, Parameswaran N Hari, et al.
World Journal of Stem Cells|April 29, 2014
Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directionsAbraham S Kanate, Marcelo C Pasquini, Parameswaran N Hari, et al.
Experimental Hematology & Oncology|December 13, 2019
Gut microbiome and CAR-T therapyMuhammad Bilal Abid, Nirav N Shah, Theresa C Maatman, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2013
Multiple myeloma: future directions in autologous transplantation and novel agentsParameswaran N Hari, Philip L McCarthy
The New England Journal of Medicine|October 1, 2015
Ibrutinib in Refractory Classic Hodgkin's LymphomaMehdi Hamadani, Sriram Balasubramanian, Parameswaran N Hari
Expert Review of Hematology|May 3, 2014
Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of ageLaura C Michaelis, Mehdi Hamadani, Parameswaran N Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myelomaLuciano J Costa, Jia-Xing Huang, Parameswaran N Hari
Leukemia & Lymphoma|April 23, 2016
Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validityLuciano J Costa, Parameswaran N Hari, Shaji K Kumar
World Journal of Transplantation|October 1, 2015
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomasNarendranath Epperla, Timothy S Fenske, Parameswaran N Hari, et al.
Bone Marrow Transplantation|August 10, 2020
Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challengesBinod Dhakal, Parameswaran N Hari, Saad Z Usmani, et al.
Statistics in Medicine|January 9, 2017
Instrumental variable with competing risk modelCheng Zheng, Ran Dai, Parameswaran N Hari, et al.
World Journal of Stem Cells|April 29, 2014
Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directionsAbraham S Kanate, Marcelo C Pasquini, Parameswaran N Hari, et al.
Experimental Hematology & Oncology|December 13, 2019
Gut microbiome and CAR-T therapyMuhammad Bilal Abid, Nirav N Shah, Theresa C Maatman, et al.
Pageof 8